These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 12518425)

  • 21. NK cells in innate immunity.
    Hamerman JA; Ogasawara K; Lanier LL
    Curr Opin Immunol; 2005 Feb; 17(1):29-35. PubMed ID: 15653307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity.
    Andoniou CE; van Dommelen SL; Voigt V; Andrews DM; Brizard G; Asselin-Paturel C; Delale T; Stacey KJ; Trinchieri G; Degli-Esposti MA
    Nat Immunol; 2005 Oct; 6(10):1011-9. PubMed ID: 16142239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor and viral recognition by natural killer cells receptors.
    Arnon TI; Markel G; Mandelboim O
    Semin Cancer Biol; 2006 Oct; 16(5):348-58. PubMed ID: 16893656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural killer cells and innate immunity to protozoan pathogens.
    Korbel DS; Finney OC; Riley EM
    Int J Parasitol; 2004 Dec; 34(13-14):1517-28. PubMed ID: 15582528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Keeping NK cells in highly regulated antiviral warfare.
    Lee SH; Miyagi T; Biron CA
    Trends Immunol; 2007 Jun; 28(6):252-9. PubMed ID: 17466596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural killer cells of Parkinson's disease patients are set up for activation: a possible role for innate immunity in the pathogenesis of this disease.
    Mihara T; Nakashima M; Kuroiwa A; Akitake Y; Ono K; Hosokawa M; Yamada T; Takahashi M
    Parkinsonism Relat Disord; 2008; 14(1):46-51. PubMed ID: 17702627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decoding the patterns of self and nonself by the innate immune system.
    Medzhitov R; Janeway CA
    Science; 2002 Apr; 296(5566):298-300. PubMed ID: 11951031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Killer cell immunoglobulin-like receptor diversity: balancing signals in the natural killer cell response.
    Parham P
    Immunol Lett; 2004 Mar; 92(1-2):11-3. PubMed ID: 15081521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy.
    Norris S; Doherty DG; Curry M; McEntee G; Traynor O; Hegarty JE; O'Farrelly C
    Cancer Immunol Immunother; 2003 Jan; 52(1):53-8. PubMed ID: 12536240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What is natural in natural killer cells?
    Vivier E
    Immunol Lett; 2006 Sep; 107(1):1-7. PubMed ID: 16930725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surface NK receptors and their ligands on tumor cells.
    Moretta L; Bottino C; Pende D; Castriconi R; Mingari MC; Moretta A
    Semin Immunol; 2006 Jun; 18(3):151-8. PubMed ID: 16730454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections.
    Terunuma H; Deng X; Dewan Z; Fujimoto S; Yamamoto N
    Int Rev Immunol; 2008; 27(3):93-110. PubMed ID: 18437601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer Immunotherapy by coordinated stimulation of innate lymphocytes (NK and NKT cells).
    Fujii S
    Rinsho Ketsueki; 2009 May; 50(5):364-74. PubMed ID: 19483396
    [No Abstract]   [Full Text] [Related]  

  • 34. Learning how to discriminate between friends and enemies, a lesson from Natural Killer cells.
    Bottino C; Moretta L; Pende D; Vitale M; Moretta A
    Mol Immunol; 2004 Jul; 41(6-7):569-75. PubMed ID: 15219995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenetics. Soaring costs in defence.
    Parham P
    Nature; 1999 Oct; 401(6756):870-1. PubMed ID: 10553900
    [No Abstract]   [Full Text] [Related]  

  • 36. Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors.
    Hoare HL; Sullivan LC; Clements CS; Ely LK; Beddoe T; Henderson KN; Lin J; Reid HH; Brooks AG; Rossjohn J
    J Mol Biol; 2008 Apr; 377(5):1297-303. PubMed ID: 18339401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural killer cells inhibit hepatitis C virus expression.
    Li Y; Zhang T; Ho C; Orange JS; Douglas SD; Ho WZ
    J Leukoc Biol; 2004 Dec; 76(6):1171-9. PubMed ID: 15339939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. gammadelta-T cells expressing NK receptors predominate over NK cells and conventional T cells in the innate IFN-gamma response to Plasmodium falciparum malaria.
    D'Ombrain MC; Hansen DS; Simpson KM; Schofield L
    Eur J Immunol; 2007 Jul; 37(7):1864-73. PubMed ID: 17557374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DAP12: an adapter protein with dual functionality.
    Takaki R; Watson SR; Lanier LL
    Immunol Rev; 2006 Dec; 214():118-29. PubMed ID: 17100880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural killer cells: from CD3(-)NKp46(+) to post-genomics meta-analyses.
    Walzer T; Jaeger S; Chaix J; Vivier E
    Curr Opin Immunol; 2007 Jun; 19(3):365-72. PubMed ID: 17442558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.